Our Pricing

The Science Behind Mounjaro Clicks Chart

Understanding the mounjaro clicks chart uk explained is essential for safe, effective treatment with tirzepatide injections. At Cured Pharmacy, our UK-registered clinical team provides comprehensive guidance on Mounjaro pen mechanics, dose escalation protocols, and click counting to ensure optimal outcomes from your weight loss treatment.

How the Mounjaro KwikPen Click System Works

The Mounjaro KwikPen uses a precision click mechanism to deliver accurate tirzepatide doses subcutaneously. Each audible click represents a fixed increment of medication, allowing patients to dial their prescribed dose with confidence. The pen contains 2.5ml of solution at varying concentrations depending on the prescribed strength (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, or 15mg per 0.5ml injection) [1].

Unlike older injection systems, the KwikPen features a dose selector window that displays your selected dose numerically, alongside the corresponding number of clicks. This dual-confirmation system significantly reduces dosing errors and has been validated in clinical practice across the SURPASS trial programme [1][2].

The pen mechanism locks automatically when the maximum dose for that pen strength is reached, preventing accidental overdosing. Each pen delivers four weekly doses at the prescribed strength, with clear visual indicators showing remaining medication volume through the transparent cartridge window.

Mounjaro Dose Escalation Schedule and Click Adjustments

Mounjaro treatment follows a structured dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. The standard UK-licensed schedule begins at 2.5mg weekly for four weeks, then increases to 5mg weekly [2].

Your prescriber may continue escalating your dose every four weeks (7.5mg, 10mg, 12.5mg, up to a maximum maintenance dose of 15mg weekly) based on your tolerance and clinical response. In the SURPASS-1 trial, patients on escalated doses achieved significantly greater HbA1c reductions and weight loss compared to those maintained on lower doses [2][3].

Each dose increase requires a new pen strength, as the click mechanism is calibrated specifically for that concentration. When transitioning from 5mg to 7.5mg, for example, you'll receive a new pen pre-filled with the higher concentration — the number of clicks required to deliver 0.5ml remains consistent, but the medication strength per injection increases.

Why Gradual Escalation Matters

The four-week intervals between dose increases allow your gastrointestinal system to adapt to tirzepatide's effects on gastric emptying and appetite regulation. Clinical data from the SURPASS-3 trial demonstrated that patients following the structured escalation protocol experienced 40% fewer treatment discontinuations due to nausea compared to those escalated more rapidly [3].

Your UK prescriber at Cured Pharmacy will review your progress at each dose level, assessing both tolerability and weight loss trajectory before recommending further increases. Some patients achieve their target weight loss at lower maintenance doses (7.5mg or 10mg), whilst others require the full 15mg dose for optimal results.

Mounjaro Clicks Chart: Dose-Specific Guidance

Each Mounjaro pen strength requires a specific click count to deliver the standard 0.5ml weekly injection. The 2.5mg pen delivers 2.5mg per 0.5ml with 12 clicks, whilst the 5mg pen delivers 5mg per 0.5ml with the same volume but different concentration. Understanding your prescribed pen's click chart prevents dosing confusion.

The dose selector on your pen rotates clockwise to increase the dose, with each click representing a precise increment. Once you reach your prescribed number of clicks (visible in the dose window), the pen is ready for injection. The plunger button requires firm, steady pressure to deliver the full dose over approximately 10 seconds [1].

After injection, the dose window should return to zero, confirming complete delivery. If any dose remains visible, the injection may have been incomplete — contact your prescriber before your next scheduled dose to confirm the appropriate course of action.

Common Click Counting Errors to Avoid

The most frequent error occurs when patients count clicks audibly but fail to verify the dose window display. Always confirm both the click count and the numerical display match your prescribed dose before injecting. Another common mistake involves rotating the selector past the prescribed dose, then rotating backwards — this can introduce air bubbles and affect dose accuracy.

If you accidentally dial past your dose, you must dispose of that pen and use a new one, as backwards rotation compromises the mechanism's precision. Cured Pharmacy's clinical team provides detailed video demonstrations during your consultation to ensure proper technique from your first injection.

Comparing Mounjaro to Other Injectable Weight Loss Treatments

Mounjaro's dual GIP/GLP-1 receptor agonist mechanism distinguishes it from single-pathway alternatives available through UK pharmacies. Wegovy (semaglutide) and Saxenda (liraglutide) both target GLP-1 receptors exclusively, whilst Mounjaro's additional GIP activation produces enhanced metabolic effects and greater average weight loss in head-to-head trials [4].

The SURPASS-2 trial directly compared tirzepatide to semaglutide 1mg weekly, demonstrating superior weight reduction across all tirzepatide dose levels. Patients receiving 15mg tirzepatide weekly achieved an average 12.4kg additional weight loss compared to the semaglutide group over 40 weeks [4].

Injection frequency differs between treatments: both Mounjaro and Wegovy require once-weekly administration, whilst Saxenda necessitates daily injections. The convenience of weekly dosing improves long-term adherence, a critical factor in sustained weight management outcomes.

Mounjaro Pricing and Availability at Cured Pharmacy

Mounjaro is available at Cured Pharmacy from £135.00 per four-week supply, with transparent upfront pricing displayed before your consultation. All prescription weight loss treatments require clinical assessment by a UK-registered prescriber, completed through our secure online consultation platform in under three minutes.

Your final cost depends on the prescribed dose strength and treatment duration. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all dispensing to ensure you receive genuine UK-licensed Mounjaro pens with full MHRA regulatory approval. We guarantee the lowest prices in the UK, with no hidden fees or subscription requirements.

Delivery is fully discreet via tracked courier, typically arriving within 24-48 hours of prescriber approval. If Mounjaro is temporarily unavailable or clinically unsuitable based on your medical history, our prescribers can recommend alternative treatments with similar efficacy profiles.

What's Included in Your Mounjaro Treatment

Every Mounjaro prescription from Cured Pharmacy includes comprehensive patient information leaflets, injection technique guides, and access to our clinical support team throughout your treatment. Your initial supply covers the starter dose (2.5mg weekly for four weeks), with follow-up prescriptions issued as you progress through the escalation schedule.

We provide sharps disposal containers with each order and detailed guidance on safe needle handling. Ongoing clinical reviews ensure your treatment remains appropriate and effective as you advance toward your weight loss goals.

Safety Considerations and Side Effect Management

The most common side effects associated with Mounjaro are gastrointestinal in nature, including nausea, diarrhoea, vomiting, and constipation. These symptoms typically emerge during the initial weeks of treatment or following dose escalations, then diminish as your body adapts to the medication [1][2].

In the pooled SURPASS trial data, approximately 12% of patients experienced nausea at the 2.5mg starting dose, increasing to 18% at the 15mg maintenance dose. However, fewer than 5% of patients discontinued treatment due to gastrointestinal side effects when following the recommended escalation schedule [3].

Serious but rare side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking concurrent diabetes medications). Mounjaro carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans. You should not use Mounjaro if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [1].

Your UK prescriber will review your complete medical history during consultation to identify any contraindications. If you experience severe abdominal pain, persistent vomiting, or signs of allergic reaction, discontinue use and seek immediate medical attention.

Optimising Your Mounjaro Experience

To minimise gastrointestinal side effects, inject Mounjaro on the same day each week, preferably in the evening after a light meal. Avoid high-fat foods during the first few weeks of treatment, as tirzepatide slows gastric emptying and may exacerbate nausea when combined with heavy meals.

Adequate hydration is essential, particularly if you experience vomiting or diarrhoea. Aim for at least two litres of water daily, and consider electrolyte supplementation if gastrointestinal symptoms persist beyond the first week at a new dose level. Our clinical team at Cured Pharmacy can provide personalised guidance on managing side effects whilst continuing your weight loss journey.

Scientific References

1. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14298
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4
4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro (tirzepatide) is a prescription-only medication licensed by the MHRA for weight management in adults with a BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities, as an adjunct to a reduced-calorie diet and increased physical activity. Individual results may vary. Always consult a qualified healthcare professional before starting any new medication or weight loss programme.